期刊文献+

Ghrelin对血管紧张素Ⅱ诱导的人脐静脉内皮细胞损伤保护作用的研究 被引量:3

Protective Effect of Ghrelin on Human Umbilical Vein Endothelial Cells (HUVECs) Injury Induced by AngiotensinⅡ(AngⅡ) in Vitro
下载PDF
导出
摘要 目的研究促生长激素释放肽Ghrelin对血管紧张素Ⅱ(AngⅡ)体外诱导人脐静脉内皮细胞(HUVECs)损伤的保护作用。方法体外培养的HUVECs,随机分为6组:正常对照组;Ghrelin(10-7mol/L)组;AngⅡ(10-7mol/L)组;AngⅡ(10-7mol/L)+Ghrelin不同浓度组:(Ghrelin10-8mol/L、10-7mol/L和10-6mol/L三个浓度组)。每组设6个复孔。用AngⅡ和Ghrelin联合干预细胞18h后,采用放射免疫方法测定内皮素-1(ET-1)含量;硝酸还原酶法测定一氧化氮(NO)含量;流式细胞仪检测细胞内活性氧(ROS)水平。结果Ghrelin呈浓度依赖性地显著减少AngⅡ诱导人脐静脉内皮细胞的ROS生成及ET-1释放,且明显促进NO生成(P<0.05)。结论Ghrelin对AngⅡ体外诱导的HUVECs损伤有保护作用。 Objective To investigate the protective effect ofghrelin on the injury of HUVECs induced by Ang Ⅱ. Method HUVECs cultured in vitro were randomly divided into 6 groups:control group; Ghrelin group (10^-7tool/L) ; Ang Ⅱ group(10^-7mol/L); Ang Ⅱ (10^-7mol/L) + Ghrelin (10^-7mol/L) group ; Ang Ⅱ (10^-7mol/L) + Ghrelin(1 0^-7mol/L) group and Ang Ⅱ (10^-7mol/L)+ Ghrelin (10^-8mol/L) group, there were 6 multiple pores in each group. After being coincubated for 18 hours by Ang Ⅱ and ghrelin, intracellular ROS levels were detected by flow cytometry (FCM), ET-1 and NO were measured by radioimmunoassay and nitrate reduction test respectively. Result Ghrelin caused a significant decrease of production of ROS and the release of EY-1,while significantly increased the production of NO (P 〈 0.05) in HUVECs induced by Ang Ⅱ .Conclusion Ghrelin (10^-7mol/L 10^-6mol/L) can protect HUVECs against injury, induced by Ang Ⅱ.
出处 《中国微循环》 北大核心 2008年第5期293-295,298,共4页 Journal of Chinese Microcirculation
关键词 GHRELIN 血管紧张素Ⅱ 人脐静脉内皮细胞 ROS 内皮素-1 一氧化氮 Ghrelin Angiotensin Ⅱ Human umbilical vein endothelial cells ROS Endothelin- 1 NO
  • 相关文献

参考文献15

  • 1Kojima M, Hosoda H, Date Y. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach [ J ] . Nature, 1999,402 ( 6762 ) :656 - 660.
  • 2Iglesias M J, Pineiro R, Blanco M, et al. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes [ J ] . Cardiovasc Res, 2004 62( 3 ) : 481 - 488.
  • 3Kleinz MJ, Maguire JJ, Skepper, et al. Functional and immunoc)lochemical evidence for a role of ghrelin and des--octanoyl ghrelin in the regulation of vascular tone in man [ J ] .Cardiovasc Res, 2006,69 ( 1 ) : 227 - 235
  • 4Nagaya N, Moriya J, Yasumttra Y, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure [ J ] . Circulation, 2004,110 ( 24 ) : 3674 - 3679.
  • 5Li WG, Gavrila D, Liu X, et al. Ghrelin inhibits proinflammatory responses and nuclear factor kappaB activation in human endothelial ceils [ J ] . Circulation, 2004, 109 ( 18 ) : 2221 -2226.
  • 6Baldanzi G, Filigheddu N, Cutrupi S, et ah Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial ceils through ERKI/2 and P! 3-kinase/AKT [J ] . JCell Biol. 2002, 159 ( 6 ) : 1029 - 1033.
  • 7Chang L, Ren Y, L iu X, et al. Protective effects ofghrelin on ischemia/reperfusion injury in the isolated rat heart [ J ] . J Cardiovasc Phannacol, 2004,43 ( 2 ) : 165 - 170.
  • 8冯丹,徐江,邹军.Omapatrilat对AngⅡ致人血管内皮细胞损伤的保护作用研究[J].中国药理学通报,2005,21(12):1498-1501. 被引量:6
  • 9Lee WS, Yang HY, Kao PF, et al. Tetramethylpyrazine downregulates angiotensin Ⅱ-induced Endothelin-I gene expression in vascular endothelial cells [ J ] . Clinical and Experimental Pharmacology and Physiology, 2005,32 ( 10 ) : 845 - 850.
  • 10Desideri G, Bravi MC, Tucci M, et al. Angiotensin Ⅱ inhibits endothelial cell motility through an ATI -dependent oxidant-sensitive decrement of nitric oxide availability [ J ] . Artefioscler Thromb vasc Biol, 2003,23 ( 7 ) : 1218 - 1223.

二级参考文献13

  • 1Cline DB,Pollak ES,Buck CA et al.Endothelial cells in physiology and in the pathophysiology of vascular disorders[J].Blood,1998,91:3527-61.
  • 2McClean DR,Ikram H,Garlick AH et al.The clinical,cardiac,renal,arterial and neurohormonal effects of omapatrilat,a vasopeptidase inhibitor,in patients with chronic heart failure[J].J Am Coll Cardiol,2000;36:479-86.
  • 3Xu J,Carretero OA,Liu YH et al.Dual Inhibition of ACE and NEP Provides Greater Cardioprotection in Mice with Heart Failure[J].Journal of Cardiac Failure,2004,10(1):83-9.
  • 4Dimmeler S,Rippmann V,Weiland U et al.AngiotensinⅡ induces apoptosis of human endothelial cells.Protective effect of nitric oxide[J].Cir Res,1997,81:970-6.
  • 5Iyer RA,Mitroka J,Maihotra B et al.metabolism of omapatrilat,a sulfhydryl containing vasopeptidase inhibitor in humans[J].Drug Metab Dispos,2001,29(1):60-9.
  • 6Erdos EG,Skidgel RA.Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones[J].FASEB J,1989,3:145-51.
  • 7Corti R,Burnett JC Jr,Rouleau JL et al.Vasopeptidase inhibitors a new therapeutic concept in cardiovascular disease[J]? Circulation,2001,104(15):1856-62.
  • 8Graf K,Grafe M,Bossaller C et al.Degradation of bradykinin by neutral endopeptidase (EC 3.4.24.11)incultured human endothelial cells[J].Eur J Clin Chem Clin Biochem,1993,31:267-72.
  • 9Schmaier AH.The plasma kallikrein/kinin system counterbalances the rennin angiotensin system[J].J Clin Invest,2002,109:1007-9.
  • 10Trippodo NC,Robl JA,Asaad MM et al.Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure[J].J Pharmacol Exp Ther,1995,275:745-52.

共引文献5

同被引文献22

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部